Explore our collection of PDF documents and enrich your knowledge now!
back
August Debouzy advised three investment funds on their acquisition of an equity interest in DNA Script
Communiqué Tax Law Employment and Social Security Law Financing IT and Data Protection Commercial and International Contracts Public Law and Public Procurement Law M&A | 10/11/21 | 2 min. | Julien Aucomte Maxime Legourd Myles Begley Alexandra Berg-Moussa Aurélien Micheli Nathalie Lengaigne Sonia Moreau Boris Léone-Robin Alexandre Dumortier Philippe Lorentz Elie Bétard Vincent Brenot Guillaume Potin Florence Chafiol Roxane Blanc-Dubois François Pochart Eden Gall Geoffroy Thill Marie Edelstenne Charles Bouffier Laure Khemiri Laure Bonin Emmanuel Le Galloc'h
August Debouzy advised Coatue Management, Catalio Capital Management, and Fidelity Management and Research on their acquisition of an equity interest in DNA Script, a pioneer in DNA printing, as part of a €142 million Series C financing round involving seven new investors.
As a French company with a unique enzymatic DNA synthesis (EDS) technology, DNA Script has expanded its capital base and capital-raising efforts in order to market its new DNA printer called Syntax. This technological innovation makes it possible to print in record time all DNA fragments required to develop messenger RNA (mRNA) vaccines.
August Debouzy advised the lead investors in this capital raising: Coatue Management, a global technology-focused investment firm, Catalio Capital Management, a global investment firm dedicated to breakthrough biomedical technology companies, and Fidelity Management and Research, one of the world's leading third-party asset managers. Columbia Threadneedle Investments, Arrowmark Partners, Farallon Capital and Moore Strategic Ventures also joined DNA Script’s capital.
August Debouzy advised Coatue Management, Catalio Capital Management and Fidelity Management and Research, with a team consisting of Julien Aucomte (Partner), Laure Khemiri (Senior Lawyer), Maxime Legourd (Lawyer) and Myles Begley (Lawyer), on the transactional aspects. With regard to the audit, the team was composed of Alexandra Berg-Moussa (Partner), Aurélien Micheli (Lawyer), Nathalie Lengaine (Counsel), Sonia Moreau (Counsel), Boris Léone-Robin (Senior Lawyer), Alexandre Dumortier (Lawyer), Philippe Lorentz (Partner), Elie Bétard (Senior Lawyer), Vincent Brenot (Partner), Guillaume Potin (Lawyer), Laure Bonin (Partner), Emmanuel Le Galloc'h (Lawyer), Florence Chafiol (Partner), Roxane Blanc-Dubois (Senior Lawyer), François Pochart (Partner), Charles Bouffier (Counsel), Eden Gall (Lawyer), Geoffroy Thill (Senior IP Counsel), Laure Arnon Duquesnoy (Senior Lawyer) and Marie Edelstenne (Lawyer).
DNA Script was assisted by Goodwin Procter, with Anne-Charlotte Rivière (Partner) and Johann Gandilhon (Lawyer), and Columbia Threadneedle Investments was advised by Clifford Chance LLP, with Chris Grey (Senior Lawyer).